Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription 10.11.2025 1 AJR Am J Roentgenol 3 Am Heart J 1 Angiology 1 Ann Intern Med 1 Can J Cardiol 1 Cardiovasc Res 18 Catheter Cardiovasc Interv 1 Circ Cardiovasc Imaging 3 Circ Genom Precis Med 1 Circ Res 2 Circulation 1 Clin Cardiol 5 J Am Coll Cardiol 1 J Clin Epidemiol 1 J Mol Cell Cardiol 2 JAMA 1 Mol Cell Biochem 1 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. LEE JW, Kim JY, Han K, Lee KH, et al
   Utility of CAD-RADS 2.0 Plaque Burden Grades and Stenosis Categories on Coronary CTA for Predicting Cardiac Events in Patients With Acute Chest Pain: A Multicenter Study.
   AJR Am J Roentgenol. 2025;225:e2533005.
   PubMed         Abstract available
   
   

   
   Am Heart J

2. MONTALESCOT G, Bolognese L, Bartus S, Cequier-Fillat A, et al
   Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Design of the AMUNDSEN Trial.
   Am Heart J. 2025 Nov 3:107295. doi: 10.1016/j.ahj.2025.107295.
   PubMed         Abstract available
   
   
3. MAHMOUDI M, Nicholas Z, Jabbour RJ, Shambrook J, et al
   Anatomical, physiological and inflammatory characterization of non-culprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rationale and design of the PICNIC study.
   Am Heart J. 2025 Nov 3:107298. doi: 10.1016/j.ahj.2025.107298.
   PubMed         Abstract available
   
   
4. BOEDDINGHAUS J, Bima P, Crisanti L, Keller DI, et al
   PRospective Evaluation of the European Society of Cardiology 0/1h-algorithm;s Safety and Efficacy for Triage of Patients with Suspected Myocardial Infarction (PRESC1SE-MI): Rationale and design of a prospective international multicenter stepped-wedge
   Am Heart J. 2025 Oct 31:107299. doi: 10.1016/j.ahj.2025.107299.
   PubMed         Abstract available
   
   

   
   Angiology

5. AKBOGA YE, Akboga MK
   Letter: Predictors of ST-Segment Resolution in ST-Elevation Myocardial Infarction Patients.
   Angiology. 2025 Nov 2:33197251390097. doi: 10.1177/00033197251390097.
   PubMed        
   
   

   
   Ann Intern Med

6. HEERSPINK HJL, Grams ME, Sang Y, Ballew SH, et al
   Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysis.
   Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-02117.
   PubMed         Abstract available
   
   

   
   Can J Cardiol

7. MAHAJAN K, Rana V
   Enhancing Clinical Relevance of AI-Based Risk Prediction in Acute Myocardial Infarction.
   Can J Cardiol. 2025 Nov 1:S0828-282X(25)01299-1. doi: 10.1016/j.cjca.2025.
   PubMed        
   
   

   
   Cardiovasc Res

8. BUGIARDINI R, Rahaman T, Manfrini O, Maas A, et al
   Diet and sex inequities in ischemic heart disease mortality across Europe: findings from the global burden of disease study.
   Cardiovasc Res. 2025 Nov 3:cvaf176. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Catheter Cardiovasc Interv

9. LIU J, Zhang J, Lin W, Li Y, et al
   Coronary Flow Reserve Measured by Myocardial Perfusion Imaging in Patients Following Percutaneous Coronary Intervention.
   Catheter Cardiovasc Interv. 2025 Aug 29. doi: 10.1002/ccd.70109.
   PubMed         Abstract available
   
   
10. BEHNES M, Schmidberger M, Vadala G, Moroni A, et al
    Prevalence and Prognostic Impact of Coronary Chronic Total Occlusions in Patients With Cardiogenic Shock.
    Catheter Cardiovasc Interv. 2025;106:2805-2815.
    PubMed         Abstract available
    
    
11. STREPKOS D, Jalli S, Mutlu D, Brilakis ES, et al
    Three Birds With One Stone: Successful Recanalization of Three Chronic Total Occlusions in a Single Procedure.
    Catheter Cardiovasc Interv. 2025;106:3120-3124.
    PubMed         Abstract available
    
    
12. OKAMOTO N, Egami Y, Fujii S, Mikako K, et al
    Comparison of Artificial Intelligence Automated Quantification and Visual Assessment in Optical Coherence Tomography Images (CONTEST).
    Catheter Cardiovasc Interv. 2025;106:3073-3083.
    PubMed         Abstract available
    
    
13. PINEDO-AVILA JB, Valera-Cabrera JL, Avalos-Rodriguez A, Fernandez-Poma SM, et al
    Ticagrelor Versus Clopidogrel in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2025 Sep 9. doi: 10.1002/ccd.70155.
    PubMed         Abstract available
    
    
14. EKMEJIAN A, Allahwala U, Bahl R, Sen S, et al
    Impact of Epicardial plaQUe Composition and geomeTry on Coronary hEmodynamics and Flow in Patients With Coronary Artery Disease (iEquate).
    Catheter Cardiovasc Interv. 2025;106:3034-3046.
    PubMed         Abstract available
    
    
15. VASSILEV DI, Mileva NB, Yaneva-Sirakova T, Georgiev RS, et al
    Validation of Coronary Wire for the Acquisition of Intracoronary Electrocardiogram in Swine.
    Catheter Cardiovasc Interv. 2025;106:3030-3033.
    PubMed         Abstract available
    
    
16. TARTAGLIA F, Basavarajaiah S, Gitto M, Cozzi OF, et al
    Drug-Coated Balloons Versus Drug-Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB-CIRCO Registry.
    Catheter Cardiovasc Interv. 2025;106:2958-2968.
    PubMed         Abstract available
    
    
17. ABOUELENIEN MM, Tanas Y, Mekky ME, Elgendy R, et al
    Long-Term Safety and Efficacy of Ultrathin Bioabsorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2025 Sep 5. doi: 10.1002/ccd.70147.
    PubMed         Abstract available
    
    
18. CHU G, Cheng L, Zhang K
    Carotid Artery Stenting Versus Carotid Endarterectomy for Carotid Artery Stenosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Catheter Cardiovasc Interv. 2025 Sep 3. doi: 10.1002/ccd.70133.
    PubMed         Abstract available
    
    
19. HELAL A, Abdelrazik A, Hogrefe K
    Safety of Everolimus and Sirolimus-Eluting Coronary Devices in a Patient With Porphyria Presenting With Acute Coronary Syndromes: A Two-Year Follow-Up.
    Catheter Cardiovasc Interv. 2025;106:2901-2905.
    PubMed         Abstract available
    
    
20. GARIN D, Arroyo D, Iglesias JF, Saidi RM, et al
    Coronary Angiography-Derived Murray Law-Based Quantitative Flow Ratio (muQFR) After De Novo Drug-Coated Balloon Angioplasty.
    Catheter Cardiovasc Interv. 2025 Sep 2. doi: 10.1002/ccd.70150.
    PubMed         Abstract available
    
    
21. YOSHIMACHI F, Yamaji K, Kohsaka S, Kawamura Y, et al
    Procedural Characteristics and Safety of Slender Percutaneous Coronary Intervention: Slender Is Better.
    Catheter Cardiovasc Interv. 2025 Sep 2. doi: 10.1002/ccd.70140.
    PubMed         Abstract available
    
    
22. BASKURT AA, Senoz O, Demir Y, Bakir EO, et al
    Comparison of Fixed-Dose Clopidogrel/Asetylsalicylic Acid Combination and Standard Loading Strategy During Percutaneous Coronary Intervention in Chronic Coronary Syndrome.
    Catheter Cardiovasc Interv. 2025 Sep 2. doi: 10.1002/ccd.70136.
    PubMed         Abstract available
    
    
23. ARAIN SA, Nascimbene A, Yarrabothula A, Hudson J, et al
    Intravascular Ultrasound Findings Associated With Hydrodynamic Contrast Recanalization (HDR) of Coronary Chronic Total Occlusions.
    Catheter Cardiovasc Interv. 2025 Sep 2. doi: 10.1002/ccd.70094.
    PubMed         Abstract available
    
    
24. ELDESOUKY M, Jaiswal S, Badra A, De-Silva S, et al
    Clinical Outcomes of Computed Tomography Coronary Angiography (CTCA) in Patients With Suspected Coronary Artery Disease: A Single-Center Experience.
    Catheter Cardiovasc Interv. 2025 Sep 1. doi: 10.1002/ccd.70135.
    PubMed         Abstract available
    
    
25. NAKANO Y, Okutsu M, Hino R, Nagata T, et al
    A Novel Cardiac Computed Tomography-Based Calcium Scoring System for Predicting the Use of Atherectomy Devices in Severely Calcified Coronary Lesions.
    Catheter Cardiovasc Interv. 2025 Sep 1. doi: 10.1002/ccd.70123.
    PubMed         Abstract available
    
    
26. KHARSA C, Olek D, Sella G, Kritya M, et al
    Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis.
    Catheter Cardiovasc Interv. 2025;106:2870-2879.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

27. XUE R, Liu J, Wang H, Wu X, et al
    Sex-Specific Prognostic Differences Between CACS and Lp(a) in Atherosclerotic Cardiovascular Disease Events: The MESA Study.
    Circ Cardiovasc Imaging. 2025 Nov 6:e018413. doi: 10.1161/CIRCIMAGING.125.018413
    PubMed         Abstract available
    
    

    
    Circ Genom Precis Med

28. FULLENKAMP DE, Wilsbacher LD, Tadros HJ, Arora P, et al
    Precision Medicine and the FDA Modernization Act 2.0: Catalyzing Innovation in Cardiovascular Therapy.
    Circ Genom Precis Med. 2025 Nov 3. doi: 10.1161/CIRCGEN.125.005487.
    PubMed         Abstract available
    
    
29. LOCKHART SM, Puri A, Zhao Y, Saudek V, et al
    Rare Variants in HTRA1, SGTB, and RBM12 Confer Risk of Atherosclerotic Cardiovascular Disease Independent of Traditional Cardiovascular Risk Factors.
    Circ Genom Precis Med. 2025 Nov 5:e005233. doi: 10.1161/CIRCGEN.125.005233.
    PubMed         Abstract available
    
    
30. WAHRENBERG A, Lind L, Aberg N, Habel H, et al
    Plasma Protein Profile Associated With a Family History of Early-Onset Coronary Heart Disease.
    Circ Genom Precis Med. 2025 Nov 7:e005220. doi: 10.1161/CIRCGEN.124.005220.
    PubMed         Abstract available
    
    

    
    Circ Res

31. LIU X, Zhang P, Lian Z, Yu H, et al
    CCL21 Enhances Platelet Activation and Atherothrombosis via CCR7 Activation.
    Circ Res. 2025;137:1299-1315.
    PubMed         Abstract available
    
    

    
    Circulation

32. RAPOSEIRAS ROUBIN S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al
    Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
    Circulation. 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
    PubMed         Abstract available
    
    
33. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Correction to: Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025;152:e371.
    PubMed        
    
    

    
    Clin Cardiol

34. LEE WC, Hsu WH, Lai CC, Chang WT, et al
    Evaluating the Impact of Catheter Ablation on Cardiovascular and Cerebral Outcomes in Atrial Fibrillation With Heart Failure and Preserved Ejection Fraction.
    Clin Cardiol. 2025;48:e70220.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

35. KRAMER CM, Lewis SJ, Wood MJ
    Transforming Cardiovascular Leadership Through Strategic Investment.
    J Am Coll Cardiol. 2025 Nov 5:S0735-1097(25)09821.
    PubMed        
    
    
36. AHMAD Y, Reddy RK, Yeh RW
    Beyond technical feasibility in complex percutaneous coronary intervention: lessons on equipoise, evidence and dogma from the PROCTOR Trial.
    J Am Coll Cardiol. 2025 Oct 28:S0735-1097(25)09923.
    PubMed        
    
    
37. D'ASCENZO F, Cerrato E, De Filippo O, Gaido L, et al
    Computed Tomography Angiography or Standard Care After Left Main PCI?
    J Am Coll Cardiol. 2025 Aug 26:S0735-1097(25)07401.
    PubMed         Abstract available
    
    
38. LI Z, Doudesis D, Bularga A, Wereski R, et al
    Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department: A Secondary Analysis.
    J Am Coll Cardiol. 2025;86:1738-1748.
    PubMed         Abstract available
    
    
39. MEHTA SR, Pinilla-Echeverri N, Tiong D, Kovalova T, et al
    Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial.
    J Am Coll Cardiol. 2025 Oct 25:S0735-1097(25)09815.
    PubMed         Abstract available
    
    

    
    J Clin Epidemiol

40. REDFORS B, Sandner S, Zhong J, Gaudino M, et al
    Preference-based controlled design: toward increased patients' engagement, efficiency and external validity of cardiovascular clinical trials.
    J Clin Epidemiol. 2025 Oct 31:112039. doi: 10.1016/j.jclinepi.2025.112039.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

41. SANCHEZ-LOPEZ D, Garcia-Vega D, Vinuela JE, Ferreiros-Vidal I, et al
    FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide.
    J Mol Cell Cardiol. 2025 Nov 1:S0022-2828(25)00193.
    PubMed         Abstract available
    
    

    
    JAMA

42. PANT S
    Nighttime Light Exposure Associated With Increased Cardiovascular Risk.
    JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19729.
    PubMed        
    
    
43. PANT S
    FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes.
    JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19724.
    PubMed        
    
    

    
    Mol Cell Biochem

44. WANG C, Tang H, Yang Q, Lu Y, et al
    Causal effect of systolic blood pressure on myocardial injury and mortality: insights from Mendelian randomization and a prospective group study.
    Mol Cell Biochem. 2025;480:6197-6209.
    PubMed         Abstract available
    
    

    
    N Engl J Med

45. LOK CE, Farkouh M, Hemmelgarn BR, Moist LM, et al
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
    N Engl J Med. 2025 Nov 7. doi: 10.1056/NEJMoa2513032.
    PubMed         Abstract available
    
    

    
    PLoS One

46. GENG S, Luo Y
    Mortality risk prediction in NSTE-ACS following PCI: Insights from a real-world cohort.
    PLoS One. 2025;20:e0336130.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.